These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 37375836)

  • 1. Pharmacogenetic Testing for the Pediatric Gastroenterologist: Actionable Drug-Gene Pairs to Know.
    Sandritter T; Chevalier R; Abt R; Shakhnovich V
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current use of pharmacogenetic testing: a national survey of thiopurine methyltransferase testing prior to azathioprine prescription.
    Fargher EA; Tricker K; Newman W; Elliott R; Roberts SA; Shaffer JL; Bruce I; Payne K
    J Clin Pharm Ther; 2007 Apr; 32(2):187-95. PubMed ID: 17381669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescribing Prevalence of Medications With Potential Genotype-Guided Dosing in Pediatric Patients.
    Ramsey LB; Ong HH; Schildcrout JS; Shi Y; Tang LA; Hicks JK; El Rouby N; Cavallari LH; Tuteja S; Aquilante CL; Beitelshees AL; Lemkin DL; Blake KV; Williams H; Cimino JJ; Davis BH; Limdi NA; Empey PE; Horvat CM; Kao DP; Lipori GP; Rosenman MB; Skaar TC; Teal E; Winterstein AG; Owusu Obeng A; Salyakina D; Gupta A; Gruber J; McCafferty-Fernandez J; Bishop JR; Rivers Z; Benner A; Tamraz B; Long-Boyle J; Peterson JF; Van Driest SL;
    JAMA Netw Open; 2020 Dec; 3(12):e2029411. PubMed ID: 33315113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing.
    Teml A; Schaeffeler E; Herrlinger KR; Klotz U; Schwab M
    Clin Pharmacokinet; 2007; 46(3):187-208. PubMed ID: 17328579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of thiopurines for inflammatory bowel disease in East Asia: prospects for clinical application of NUDT15 genotyping.
    Kakuta Y; Kinouchi Y; Shimosegawa T
    J Gastroenterol; 2018 Feb; 53(2):172-180. PubMed ID: 29192347
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Goh LL; Lim CW; Leong KP; Ong KH
    Front Pharmacol; 2022; 13():837164. PubMed ID: 36210828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives from the Society for Pediatric Research: pharmacogenetics for pediatricians.
    Tang Girdwood SC; Rossow KM; Van Driest SL; Ramsey LB
    Pediatr Res; 2022 Feb; 91(3):529-538. PubMed ID: 33824446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
    Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
    Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TPMT and NUDT15 Variants Predict Discontinuation of Azathioprine for Myelotoxicity in Patients with Inflammatory Disease: Real-World Clinical Results.
    Dickson AL; Daniel LL; Zanussi J; Dale Plummer W; Wei WQ; Liu G; Reese T; Anandi P; Birdwell KA; Kawai V; Cox NJ; Dupont WD; Hung AM; Feng Q; Stein CM; Chung CP
    Clin Pharmacol Ther; 2022 Jan; 111(1):263-271. PubMed ID: 34582038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC
    Blazy C; Ellingrod V; Ward K
    Front Pharmacol; 2022; 13():939313. PubMed ID: 35814245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing thiopurine therapy in children with acute lymphoblastic leukemia: A promising "MINT" sequencing strategy and therapeutic "DNA-TG" monitoring.
    Guo HL; Zhao YT; Wang WJ; Dong N; Hu YH; Zhang YY; Chen F; Zhou L; Li T
    Front Pharmacol; 2022; 13():941182. PubMed ID: 36238550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of thiopurine testing in the management of inflammatory bowel diseases in clinical practice: a worldwide survey of experts.
    Roblin X; Oussalah A; Chevaux JB; Sparrow M; Peyrin-Biroulet L
    Inflamm Bowel Dis; 2011 Dec; 17(12):2480-7. PubMed ID: 21351210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mercaptopurine induced myelosuppression in a child with a
    Gupta N; Magatha LS; Jayaraman D; Scott JX; Antony SB; Koshy T
    J Oncol Pharm Pract; 2023 Jun; 29(4):999-1001. PubMed ID: 36341754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and use of active clinical decision support for preemptive pharmacogenomics.
    Bell GC; Crews KR; Wilkinson MR; Haidar CE; Hicks JK; Baker DK; Kornegay NM; Yang W; Cross SJ; Howard SC; Freimuth RR; Evans WE; Broeckel U; Relling MV; Hoffman JM
    J Am Med Inform Assoc; 2014 Feb; 21(e1):e93-9. PubMed ID: 23978487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update.
    Relling MV; Schwab M; Whirl-Carrillo M; Suarez-Kurtz G; Pui CH; Stein CM; Moyer AM; Evans WE; Klein TE; Antillon-Klussmann FG; Caudle KE; Kato M; Yeoh AEJ; Schmiegelow K; Yang JJ
    Clin Pharmacol Ther; 2019 May; 105(5):1095-1105. PubMed ID: 30447069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450 genotype-guided drug therapies: An update on current states.
    Dong AN; Tan BH; Pan Y; Ong CE
    Clin Exp Pharmacol Physiol; 2018 Oct; 45(10):991-1001. PubMed ID: 29858511
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.